Development of BIO 300 oral tabs
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2390018
- Awardee
-
Humanetics Corporation UEI MSRQYLLQLYQ5
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $24,374,208.00
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Defense Joint PEO Chemical and Biological Defense awarded an Other Transaction IDV to Humanetics Corporation on August 10, 2023, with a ceiling of $24.37 million to support advanced development of BIO 300 oral tablets as a prophylactic medical countermeasure for acute radiation syndrome. This OT IDV operates outside the FAR procurement framework and supports the transition of an existing therapeutic candidate from preclinical development into clinical and regulatory pathways.
Humanetics Corporation is a biopharmaceutical company focused on medical countermeasures for radiation exposure. The company brings established capability in formulation development and regulatory strategy for radiation mitigation treatments, including prior work on BIO 300 and BIO 301 candidates funded through grants from the National Institutes of Health, the Department of Defense, and the Department of the Army.
The OT IDV aims to develop an oral formulation of BIO 300 as an alternative delivery mechanism to the existing therapeutic. Work encompasses the necessary preclinical and clinical studies required to achieve regulatory approval. Performance occurs at Humanetics facilities and partner sites. Task orders issued under this IDV will fund discrete development projects across the vehicle's performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $4,874,770 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $19,499,438 |
Quick answers
Who was awarded contract W911SR2390018?
W911SR2390018 was awarded to Humanetics Corporation by ACC Aberdeen Proving Ground (Army Contracting Command) on August 10, 2023.
How much is contract W911SR2390018 worth?
W911SR2390018's own ceiling is $24,374,208.
Which agency awarded contract W911SR2390018?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2390018, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2390018 competed?
The extent of competition for W911SR2390018 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV